Sight Sciences (SGHT) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SGHT Stock Forecast

Sight Sciences stock forecast is as follows: an average price target of $9.00 (represents a 136.84% upside from SGHT’s last price of $3.80) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.

SGHT Price Target

The average price target for Sight Sciences (SGHT) is $9.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $5.00. This represents a potential 136.84% upside from SGHT's last price of $3.80.

SGHT Analyst Ratings

Hold

According to 7 Wall Street analysts, Sight Sciences's rating consensus is 'Hold'. The analyst rating breakdown for SGHT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (28.57%), 5 'Hold' (71.43%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Sight Sciences Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 04, 2024	Frank Takkinen	Loop Capital Markets	$5.00	$4.66	7.30%	31.58%
Oct 04, 2024	Frank Takkinen	Loop Capital Markets	$10.00	$5.81	72.12%	163.16%
Aug 21, 2024	Frank Takkinen	Lake Street	$10.00	$6.08	64.47%	163.16%
May 03, 2024	Matt O'Brien	Piper Sandler	$6.00	$5.70	5.26%	57.89%
Dec 12, 2022	-	Citigroup	$15.00	$12.65	18.58%	294.74%
Aug 11, 2022	Matt O'Brien	Piper Sandler	$15.00	$9.81	52.91%	294.74%

Row per page

Go to

The latest Sight Sciences stock forecast, released on Nov 04, 2024 by Frank Takkinen from Loop Capital Markets, set a price target of $5.00, which represents a 7.30% increase from the stock price at the time of the forecast ($4.66), and a 31.58% increase from SGHT last price ($3.80).

Sight Sciences Price Target by Period

	1M	3M	12M
# Anlaysts	1	3	4
Avg Price Target	$5.00	$8.33	$7.75
Last Closing Price	$3.80	$3.80	$3.80
Upside/Downside	31.58%	119.21%	103.95%

In the current month, the average price target of Sight Sciences stock is $5.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 31.58% increase as opposed to Sight Sciences's last price of $3.80. This month's average price target is down -39.98% compared to last quarter, and down -35.48% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 04, 2024	Lake Street	Buy	Buy	Downgrade
Oct 04, 2024	Lake Street	Buy	Buy	Hold
Aug 21, 2024	Lake Street	-	Buy	Initialise
Jul 15, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
Jul 10, 2024	Citigroup	Neutral	Neutral	Hold
May 03, 2024	Piper Sandler	Neutral	Neutral	Hold
Sep 12, 2023	William Blair	-	Market Perform	Downgrade
Sep 12, 2023	Piper Sandler	Overweight	Neutral	Downgrade
Jan 06, 2023	Stifel Nicolaus	-	Buy	Upgrade
Dec 12, 2022	Citigroup	Buy	Buy	Hold

Row per page

Go to

Sight Sciences's last stock rating was published by Lake Street on Nov 04, 2024. The company gave SGHT a "Buy" rating, the same as its previous rate.

Sight Sciences Financial Forecast

Sight Sciences Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Revenue	-	-	-	-	-	-	-	-	$18.75M	$20.01M	$23.47M	$18.82M	$20.54M	$18.68M	$17.23M	$14.88M	$14.69M	$13.10M	$12.54M
Avg Forecast	$23.66M	$22.41M	$22.24M	$20.19M	$20.47M	$20.40M	$21.34M	$18.40M	$18.95M	$21.59M	$22.40M	$18.87M	$20.26M	$17.68M	$16.21M	$13.28M	$14.17M	$12.07M	$12.48M
High Forecast	$24.36M	$23.08M	$22.90M	$20.65M	$21.08M	$20.52M	$21.34M	$18.40M	$20.39M	$21.59M	$23.07M	$19.43M	$20.86M	$17.68M	$16.21M	$13.28M	$14.17M	$12.07M	$12.48M
Low Forecast	$23.10M	$21.88M	$21.71M	$19.87M	$19.78M	$20.28M	$21.34M	$18.40M	$17.50M	$21.59M	$21.87M	$18.42M	$19.78M	$17.68M	$16.21M	$13.28M	$14.17M	$12.07M	$12.48M
# Analysts	1	1	1	4	5	4	1	1	3	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	0.99%	0.93%	1.05%	1.00%	1.01%	1.06%	1.06%	1.12%	1.04%	1.09%	1.00%

Sight Sciences's average Quarter revenue forecast for Mar 24 based on 1 analysts is $18.40M, with a low forecast of $18.40M, and a high forecast of $18.40M. SGHT's average Quarter revenue forecast represents a -1.89% decrease compared to the company's last Quarter revenue of $18.75M (Dec 23).

Sight Sciences EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	4	5	4	1	1	3	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	$-10.92M	$-13.41M	$-13.40M	$-15.78M	$-15.67M	$-20.90M	$-22.57M	$-22.03M	$-27.73M	$-15.41M	$-16.36M
Avg Forecast	$-21.81M	$-20.66M	$-20.50M	$-18.61M	$-18.87M	$-18.81M	$-19.68M	$-16.96M	$-17.47M	$-19.90M	$-20.65M	$-17.40M	$-18.68M	$-16.62M	$-15.24M	$-12.48M	$-13.32M	$-11.35M	$-14.73M
High Forecast	$-21.29M	$-20.17M	$-20.02M	$-18.32M	$-18.24M	$-18.70M	$-19.68M	$-16.96M	$-16.13M	$-19.90M	$-20.16M	$-16.98M	$-18.23M	$-16.62M	$-15.24M	$-12.48M	$-13.32M	$-11.35M	$-11.78M
Low Forecast	$-22.46M	$-21.28M	$-21.11M	$-19.04M	$-19.43M	$-18.91M	$-19.68M	$-16.96M	$-18.80M	$-19.91M	$-21.27M	$-17.92M	$-19.23M	$-16.62M	$-15.24M	$-12.48M	$-13.32M	$-11.35M	$-17.67M
Surprise %	-	-	-	-	-	-	-	-	0.63%	0.67%	0.65%	0.91%	0.84%	1.26%	1.48%	1.76%	2.08%	1.36%	1.11%

undefined analysts predict SGHT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Sight Sciences's previous annual EBITDA (undefined) of $NaN.

Sight Sciences Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	4	5	4	1	1	3	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	$-10.69M	$-13.04M	$-14.75M	$-17.07M	$-16.91M	$-22.23M	$-23.84M	$-23.26M	$-20.08M	$-17.17M	$-17.61M
Avg Forecast	$-9.90M	$-11.58M	$-11.24M	$-11.33M	$-11.10M	$-10.45M	$-14.92M	$-13.90M	$-15.98M	$-16.00M	$-17.20M	$-19.71M	$-21.00M	$-22.86M	$-23.15M	$-20.04M	$-19.54M	$-13.13M	$-15.86M
High Forecast	$-9.60M	$-11.22M	$-10.90M	$-6.69M	$-5.55M	$-10.13M	$-14.46M	$-13.47M	$-9.13M	$-15.51M	$-16.67M	$-19.10M	$-20.35M	$-22.86M	$-23.15M	$-20.04M	$-19.54M	$-13.13M	$-12.69M
Low Forecast	$-10.29M	$-12.03M	$-11.68M	$-14.93M	$-15.64M	$-10.86M	$-15.50M	$-14.44M	$-20.09M	$-16.63M	$-17.87M	$-20.47M	$-21.81M	$-22.86M	$-23.15M	$-20.04M	$-19.54M	$-13.13M	$-19.03M
Surprise %	-	-	-	-	-	-	-	-	0.67%	0.81%	0.86%	0.87%	0.81%	0.97%	1.03%	1.16%	1.03%	1.31%	1.11%

Sight Sciences's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SGHT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Sight Sciences SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	4	5	4	1	1	3	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	$23.47M	$26.50M	$30.06M	$28.68M	$28.70M	$31.54M	$31.43M	$28.39M	$26.41M	$20.79M	$17.76M
Avg Forecast	$35.46M	$33.59M	$33.33M	$30.26M	$30.68M	$30.58M	$31.99M	$27.57M	$28.40M	$32.36M	$33.58M	$28.28M	$30.36M	$26.50M	$24.30M	$19.91M	$21.24M	$18.10M	$18.70M
High Forecast	$36.52M	$34.60M	$34.33M	$30.95M	$31.59M	$30.75M	$31.99M	$27.57M	$30.57M	$32.36M	$34.58M	$29.13M	$31.27M	$26.50M	$24.30M	$19.91M	$21.24M	$18.10M	$18.70M
Low Forecast	$34.62M	$32.80M	$32.54M	$29.79M	$29.65M	$30.40M	$31.99M	$27.57M	$26.23M	$32.36M	$32.78M	$27.61M	$29.65M	$26.50M	$24.30M	$19.91M	$21.24M	$18.10M	$18.70M
Surprise %	-	-	-	-	-	-	-	-	0.83%	0.82%	0.90%	1.01%	0.95%	1.19%	1.29%	1.43%	1.24%	1.15%	0.95%

Sight Sciences's average Quarter SG&A projection for Mar 24 is $27.57M, based on 1 Wall Street analysts, with a range of $27.57M to $27.57M. The forecast indicates a 17.50% rise compared to SGHT last annual SG&A of $23.47M (Dec 23).

Sight Sciences EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	4	5	4	1	1	3	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	$-0.22	$-0.27	$-0.30	$-0.35	$-0.35	$-0.46	$-0.50	$-0.49	$-0.42	$-0.43	$-0.42
Avg Forecast	$-0.20	$-0.23	$-0.22	$-0.23	$-0.22	$-0.21	$-0.30	$-0.28	$-0.32	$-0.32	$-0.34	$-0.39	$-0.42	$-0.46	$-0.46	$-0.40	$-0.39	$-0.26	$-0.02
High Forecast	$-0.19	$-0.22	$-0.22	$-0.13	$-0.11	$-0.20	$-0.29	$-0.27	$-0.18	$-0.31	$-0.33	$-0.38	$-0.40	$-0.46	$-0.46	$-0.40	$-0.39	$-0.26	$-0.02
Low Forecast	$-0.20	$-0.24	$-0.23	$-0.30	$-0.31	$-0.22	$-0.31	$-0.29	$-0.40	$-0.33	$-0.35	$-0.41	$-0.43	$-0.46	$-0.46	$-0.40	$-0.39	$-0.26	$-0.02
Surprise %	-	-	-	-	-	-	-	-	0.69%	0.85%	0.88%	0.89%	0.84%	1.00%	1.08%	1.22%	1.07%	1.63%	18.95%

According to undefined Wall Street analysts, Sight Sciences's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SGHT previous annual EPS of $NaN (undefined).

Sight Sciences Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
RPID	Rapid Micro Biosystems	$1.04	$8.00	669.23%	Hold
SGHT	Sight Sciences	$3.80	$9.00	136.84%	Hold
LUNG	Pulmonx	$6.34	$11.93	88.17%	Buy
KIDS	OrthoPediatrics	$22.93	$39.60	72.70%	Buy
SIBN	SI-BONE	$12.92	$20.00	54.80%	Buy
NPCE	NeuroPace	$8.98	$12.88	43.43%	Buy
CNMD	CONMED	$72.24	$96.00	32.89%	Buy
OFIX	Orthofix Medical	$18.08	$24.00	32.74%	-
VREX	Varex Imaging	$13.70	$17.00	24.09%	Buy
AVNS	Avanos Medical	$18.68	$23.00	23.13%	Hold
CVRX	CVRx	$13.91	$16.33	17.40%	Buy
FNA	Paragon 28	$10.01	$11.50	14.89%	Buy
AORT	Artivion	$26.65	$30.60	14.82%	Buy
TCMD	Tactile Systems	$15.66	$16.00	2.17%	Buy

SGHT Forecast FAQ

Is Sight Sciences a good buy?

No, according to 7 Wall Street analysts, Sight Sciences (SGHT) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 28.57% of SGHT's total ratings.

What is SGHT's price target?

Sight Sciences (SGHT) average price target is $9 with a range of $5 to $15, implying a 136.84% from its last price of $3.8. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Sight Sciences stock go up soon?

According to Wall Street analysts' prediction for SGHT stock, the company can go up by 136.84% (from the last price of $3.8 to the average price target of $9), up by 294.74% based on the highest stock price target, and up by 31.58% based on the lowest stock price target.

Can Sight Sciences stock reach $6?

SGHT's average twelve months analyst stock price target of $9 supports the claim that Sight Sciences can reach $6 in the near future.

What is Sight Sciences's current price target trend?

1 Wall Street analyst forecast a $5 price target for Sight Sciences (SGHT) this month, up 31.58% from its last price of $3.8. Compared to the last 3 and 12 months, the average price target increased by 119.21% and increased by 103.95%, respectively.

What are Sight Sciences's analysts' financial forecasts?

Sight Sciences's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $80.61M (high $81.33M, low $79.8M), average EBITDA is $-74.314M (high $-73.574M, low $-74.98M), average net income is $-50.366M (high $-43.609M, low $-56.436M), average SG&A $120.82M (high $121.91M, low $119.62M), and average EPS is $-1.001 (high $-0.866, low $-1.121). SGHT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $88.49M (high $91M, low $86.56M), average EBITDA is $-81.578M (high $-79.801M, low $-83.892M), average net income is $-44.048M (high $-38.409M, low $-48.926M), average SG&A $132.63M (high $136.4M, low $129.75M), and average EPS is $-0.875 (high $-0.763, low $-0.972).

Did the SGHT's actual financial results beat the analysts' financial forecasts?

Based on Sight Sciences's last annual report (Dec 2023), the company's revenue was $81.06M, which missed the average analysts forecast of $81.8M by -0.91%. Apple's EBITDA was $-56.629M, missing the average prediction of $-75.418M by -24.91%. The company's net income was $-55.547M, missing the average estimation of $-68.892M by -19.37%. Apple's SG&A was $108.25M, missing the average forecast of $122.62M by -11.72%. Lastly, the company's EPS was $-1.14, missing the average prediction of $-1.369 by -16.70%. In terms of the last quarterly report (Dec 2023), Sight Sciences's revenue was $18.75M, missing the average analysts' forecast of $18.95M by -1.03%. The company's EBITDA was $-10.92M, missing the average prediction of $-17.467M by -37.48%. Sight Sciences's net income was $-10.691M, missing the average estimation of $-15.985M by -33.12%. The company's SG&A was $23.47M, missing the average forecast of $28.4M by -17.36%. Lastly, the company's EPS was $-0.22, missing the average prediction of $-0.318 by -30.72%